Titlebook: Recent Advances in Endometrial Cancer; Sumita Mehta,Bindiya Gupta Book 2020 Springer Nature Singapore Pte Ltd. 2020 Screening for endometr

只看該作者 · 發(fā)表于 2025-3-25 05:09:43

MicroRNAs: Role in Cancer and miRNA Signatures in Endometrial Cancerre only a few biomarkers that are useful in early diagnosis of the disease and guiding treatment principles. MicroRNAs which are 19–23 base pair long functional transcripts that regulate gene expression by cleavage or translational suppression of target mRNA may help in effective and minimally invas

只看該作者 · 發(fā)表于 2025-3-25 11:16:39

只看該作者 · 發(fā)表于 2025-3-25 12:59:42

只看該作者 · 發(fā)表于 2025-3-25 18:56:44

Recurrent Endometrial CancerWomen with recurrent endometrial cancer (REC) represent a heterogeneous group, with variable clinical profile and therapeutic response. Although the prognosis of endometrial cancer is largely good owing to its early detection, but the prognosis of recurrent disease remains grave, reflecting the biol

只看該作者 · 發(fā)表于 2025-3-25 23:12:19

只看該作者 · 發(fā)表于 2025-3-26 00:54:32

只看該作者 · 發(fā)表于 2025-3-26 04:24:13

MicroRNAs: Role in Cancer and miRNA Signatures in Endometrial Cancerompared to normal tissues are now well documented. Herein, we describe the role of miRNAs in cancer development and discuss how their genomic interaction will impact both research and clinical management for endometrial cancer.

只看該作者 · 發(fā)表于 2025-3-26 09:19:08

只看該作者 · 發(fā)表于 2025-3-26 14:58:36

只看該作者 · 發(fā)表于 2025-3-26 19:50:26

http://image.papertrans.cn/r/image/822729.jpg

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-31 09:07
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved